Literature DB >> 25246451

Serotonin syndrome following levodopa treatment in diffuse Lewy body disease.

Suman Kushwaha1, Akhila Kumar Panda1, Hardeep Singh Malhotra2, Manmeet Kaur1.   

Abstract

Serotonin syndrome results from an acute hyperserotonergic state. It is a rare and potentially fatal complication of drugs that affect the central nervous system serotonin levels. It is characterised by a triad of clinical features comprising altered sensorium, autonomic instability and neuromuscular hyperexcitability, in different combinations. We present an atypical case of serotonin syndrome related to levodopa use in a patient of probable Lewy body dementia. This case highlights the difficulty in diagnosis and management of cases with serotonin syndrome in the absence of history of a known serotonergic drug and the fact that levodopa can contribute to its occurrence. 2014 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25246451      PMCID: PMC4173194          DOI: 10.1136/bcr-2013-201375

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity.

Authors:  E J C Dunkley; G K Isbister; D Sibbritt; A H Dawson; I M Whyte
Journal:  QJM       Date:  2003-09

Review 2.  The serotonin syndrome.

Authors:  H Sternbach
Journal:  Am J Psychiatry       Date:  1991-06       Impact factor: 18.112

Review 3.  The serotonin syndrome.

Authors:  Edward W Boyer; Michael Shannon
Journal:  N Engl J Med       Date:  2005-03-17       Impact factor: 91.245

Review 4.  A review of serotonin toxicity data: implications for the mechanisms of antidepressant drug action.

Authors:  P Ken Gillman
Journal:  Biol Psychiatry       Date:  2006-02-07       Impact factor: 13.382

5.  L-dopa induced "serotonin syndrome" in a parkinsonian patient on bromocriptine.

Authors:  R Sandyk
Journal:  J Clin Psychopharmacol       Date:  1986-06       Impact factor: 3.153

6.  Possible development of the serotonin syndrome in man.

Authors:  T R Insel; B F Roy; R M Cohen; D L Murphy
Journal:  Am J Psychiatry       Date:  1982-07       Impact factor: 18.112

Review 7.  Overview of serotonin syndrome.

Authors:  Mohammad M Iqbal; Miles J Basil; Jonathan Kaplan; Md Touhid Iqbal
Journal:  Ann Clin Psychiatry       Date:  2012-11       Impact factor: 1.567

8.  Serotonin-dopamine interaction: an overview.

Authors:  Ennio Esposito; Vincenzo Di Matteo; Giuseppe Di Giovanni
Journal:  Prog Brain Res       Date:  2008       Impact factor: 2.453

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.